Methylglyoxal-derived modifications in lens aging and cataract formation

Investigative Ophthalmology and Visual Science

Volumn 39, Issue 12, 1998, Pages 2355-2364

  Shamsi, Farrukh A ^a   Lin, Kenneth ^a   Sady, Candace ^a   Nagaraj, Ramanakoppa H ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTATHIONE; GLYCERALDEHYDE; LENS PROTEIN; METHYLGLYOXAL; POLYCLONAL ANTIBODY;

ADULT; AGED; AGING; ANIMAL TISSUE; ARTICLE; CATARACT; CATARACTOGENESIS; CATTLE; ENZYME LINKED IMMUNOSORBENT ASSAY; GALACTOSEMIA; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; NONHUMAN; ORGAN CULTURE; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION; RAT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AGING; ANIMALS; BLOTTING, WESTERN; CATARACT; CATTLE; CHILD; CRYSTALLINS; DIABETES MELLITUS, EXPERIMENTAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GLUTATHIONE; HUMANS; LENS, CRYSTALLINE; MAILLARD REACTION; MIDDLE AGED; MONOSACCHARIDES; ORGAN CULTURE TECHNIQUES; PYRUVALDEHYDE; RABBITS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0031732522     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Dunn JA, McCance DR, Thorpe SR, Lyons TJ, Baynes JW. Age-dependent accumulation of N epsilon-(carboxymethyl)lysine and N epsilon-(carboxymethyl)hydroxylysine in human skin collagen. Biochemistry. 1991;30:1205-1210.
2. Araki N, Ueno N, Chakrabarti B, Morino Y, Horiuchi S. Immunochemical evidence for the presence of advanced glycation end products in human lens proteins and its positive correlation with aging. J Biol Chem. 1992;267:10211-10214.
3. Nagaraj RH, Monnier VM. Isolation and characterization of a blue fluorophore from human eye lens crystallins: in vitro formation from Maillard reaction with ascorbate and ribose. Biochem Biophys Acta. 1992;1116:34-42.
4. Nagaraj RH, Sady C. The presence of a glucose-derived Maillard reaction product in the human lens. FEBS Lett. 1996;382:234-238.
5. Nagaraj RH, Sell DR, Prabhakaram M, Ortwerth BJ, Monnier VM. High correlation between pentosidine protein crosslinks and pigmentation implicates ascorbate oxidation in human lens senescence and cataractogenesis. Proc Natl Acad Sci USA. 1991;88: 10257-10261.
6. Lyons TJ, Silvestri G, Dunn JA, Dyer DG, Baynes JW. Role of glycation in modification of lens crystallins in diabetic and nondiabetic senile cataracts. Diabetes. 1991;40:1010-1015.
7. Ahmed MU, Brinkmann E, Degenhardt TP, Thorpe SR, Baynes JW. N-epsilon-(carboxyethyl)lysine, a product of the chemical modification of proteins by methlyglyoxal, increases with age in human lens proteins. Biochem J. 1997;324:565-570.
8. Obayashi H, Nakano K, Shigeta H, et al. Formation of crossline as a fluorescent advanced glycation end product in vitro and in vivo. Biochem Biopbys Res Commun. 1996;226:37-41.
9. Lal S, Szwergold BS, Taylor AH, et al. Metabolism of fructose-3-phosphate in the diabetic rat lens. Arch Biochem Biophys. 1995; 318:191-199.
10. Garlick RL, Mazer JS, Chylack LT Jr, Tung WH, Bunn HF. Nonenzymatic glycation of human lens crystallin: effect of aging and diabetes mellitus. J Clin Invest. 1985;74:1742-1749.
11. Nakayama H, Mitsuhashi T, Kuwajima S, et al. Immunochemical detection of advanced glycation end products in lens crystallins from streptozotocin-induced diabetic rat. Diabetes. 1993;42:345-350.
12. Zhao HR, Nagaraj RH, Abraham EC. The role of alpha- and epsilon-amino groups in the glycation-mediated cross-linking of gamma B-crystallin. Study of three site-directed mutants. J Biol Chem. 1997;272:14465-14469.
13. Perry RE, Swamy MS, Abraham EC. Progressive changes in lens crystallin glycation and high-molecular weight aggregate formation leading to cataract development in streptozotocin-diabetic rats. Exp Eye Res. 1987;44:269-282.
14. Nagaraj RH, Monnier VM. Non tryptophan fluorescence and high molecular weight protein formation in lens crystallins of rats with chronic experimental galactosemia: prevention of by the aldose reductase inhibitor Sorbinil. Exp Eye Res. 1990;52:411-418.
15. Nagaraj RH, Prabhakaram M, Ortwerth BJ, Monnier VM. Suppression of pentosidine formation in galactosemic rat lens by an inhibitor of aldose reductase. Diabetes. 1994;43:580-586.
16. Nagaraj RH, Kern TS, Sell DR, Fogarty J, Engerman RL, Monnier VM. Evidence of a glycemic threshold for the formation of pentosidine in diabetic dog lens but not in collagen. Diabetes. 1996;45: 587-594.
17. Ortwerth BJ, Prabhakaram M, Nagaraj RH, Linetsky M. The relative UV sensitizer activity of purified advanced glycation endproducts. Photochem Photobiol. 1997;65:666-672.
18. Garner MH, Bahador A, Sachs G. Nonenzymatic glycation of Na,K-ATPase: effects on ATP hydrolysis and K+ occlusion. J Biol Chem. 1990;265:15058-15066.
19. Takahashi M, Lu YB, Myint T, Fujii J, Wada Y, Taniguchi N. In vivo glycation of aldehyde reductase, a major 3-deoxyglucosone reducing enzyme: identification of glycation sites. Biochemistry. 1995; 34:1433-1438.
20. Takata I, Kawamura N, Myint T, et al. Glycated Cu,Zn-superoxide dismutase in rat lenses: evidence for the presence of fragmentation in vivo. Biochem Biophys Res Commun. 1996;219:243-248.
21. Prabhakaram M, Katz ML, Ortwerth BJ. Glycation medicated crosslinking between alpha crystallin and MP26 in intact lens membranes. Mech Ageing Dev. 1996;91:65-78.
22. Swamy Mruthiniti S, Green K, Abraham EC. Inhibition of cataracts in moderately diabetic rats by aminoguanidine. Exp Eye Res. 1996; 62:505-510.
23. Thornalley PJ. The glyoxalase system in health and disease. Mol Aspects Med. 1993;14:287-371.
24. Phillips SA, Mirrlees D, Thornalley PJ. Modification of the glyoxalase system in streptozotocin-induced diabetic rats: effect of the aldose reductase inhibitor Statil. Biochem Pharmacol. 1993;46: 805-811.
25. Vander Jagt DL, Robinson B, Taylor KK, Haunsaker LA. Reduction of trioses by NADPH-dependent aldo-keto reductases: aldose reductase, methylglyoxal, and diabetic complications. J Biol Chem. 1992;267:4364-4369.
26. Riley LM, Harding JJ. The reaction of methylglyoxal with human and bovine lens proteins. Biochem Biophys Acta. 1995;1270:36-43.
27. Shamsi FA, Partal A, Sady C, Glomb MA, Nagaraj RH. Immunological evidence for methylglyoxal-derived modifications in vivo: determination of antigenic epitopes. J Biol Chem. 1998;273:6928-6936.
28. Shipanova IN, Glomb MA, Nagaraj RH. Protein modification by methylglyoxal: chemical nature and synthetic mechanism of a major fluorescent adduct. Arch Biochem Biophys. 1997;344:29-36.
29. Nagaraj RH, Shipanova IN, Faust FM. Protein cross-linking by the Maillard reaction: isolation, characterization, and in vivo detection of a lysine-lysine cross-link derived from methylglyoxal. J Biol Chem. 1996;271;19338-19345.
30. Wells-Knecht KJ, Brinkmann E, Wells-Knecht MC, Litchfield JE, et al. New biomarkers of Maillard reaction damage to proteins. Nephrol Dial Transplant. 1996;11:41-47.
31. Madson MA, Feather MS. An improved preparation of 3-deoxy-D-erythro-hexosulose via the bis(benzoylhydrazone) and some related constitutional studies. Carbohydr Res. 1181;94:183-191.
32. Otsuka M, Kurata T, Arawaka N. In: Fujimaki M, Namiki M, Kato H, eds. Aminocarbonyl Reactions in Food and Biological Systems. New York: Elsevier; 1985:74.
33. Moore S, Stein WH. A modified ninhydrin reagent for the photometric determination of amino acids and related compounds. J Biol Chem. 1954;211:907-913.
34. 2 and photochemically induced cataract. Curr Eye Res. 1993; 12:163-179.
35. Lou MF, Dickerson JE Jr, Garadi R, York BM Jr. Glutathione depletion in the lens of galactosemic and diabetic rats. Exp Eye Res. 1988;46:517-530.
36. Haik GM Jr, Lo TW, Thornalley PJ. Methylglyoxal concentration and glyoxalase activities in the human lens. Exp Eye Res. 1994;59: 497-500.
37. Heath H. The distribution and possible functions of ascorbic acid in the eye. Exp Eye Res. 1962;1:362-367.
38. Kern HL, Zolot SL. Transport of vitamin C in the lens. Curr Eye Res. 1987;6:895-896.
39. Lohman W, Schmehl W, Strobel J. Nuclear cataract: oxidative damage to the lens. Exp Eye Res. 1986;43:859-862.
40. Ventura L, Lam KW, Lin TYM. The difference between brunescent and opalescent nucleosclerosis. Lens Res. 1987;4:79-86.38.
41. Lopez MG, Feather MS. The production of threose as a degradation product from L-ascorbic acid. J Carbohydr Chem. 1992;11:799-806.
42. Li EY, Feather MS. The degradation of L-threose at Maillard reaction conditions. Carbobydr Res. 1994;256:41-47.
43. Tomana M, Prchal JT, Garner C, Skala HW, Barker SA. Gas chromatographic analysis of lens monosaccharides. J Lab Clin Med. 1984;103:137-142.
44. Ortwerth BJ, Speaker JA, Prabhakaram M, Lopez MG, Li EY, Feather MS. Ascorbic acid glycation: the reaction of L-threose in lens tissue. Exp Eye Res. 1994;58:665-674.
45. Charlton JM, van Heyningen R. A specific enzymic assay of D-glyceraldehyde and dihydroxyacetone. Anal Biochem. 1969;30: 313-326.
46. Davenport RC, Bash PA, Seaton BA, Karplus M, Petsko GA, Ringe D. Structure of the triosephosphate isomerase-phosphoglycolohydroxamate complex: an analogue of the intermediate on the reaction pathway. Biochemistry. 1991;30:5821-5826.
47. Berman ER. Biochemistry of the Eye. New York: Plenum Press; 1991:201-290.